Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 2Thoracic 1Gynecologic 1

Conditions

Esophageal Neoplasms 1Endobronchial Metastases 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 15Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Gemcitabine 5Drug Therapy 5Control Groups 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Ribavirin 4Hepatectomy 4HMPL-013 4Golytely 4Furazolidone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Rocuronium × Gastrointestinal × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

NCT02320734 2016-09-19

DEPTH

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Completed
66 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡